Winners and losers on Medicare drug price negotiation; a proposal for senators to fill out a legislative advance directive

HHS unveiled its long-awaited list of the 10 medicines that will be subject to price negotiation in 2026 under the Inflation Reduction Act.

August 29, 2023 Check out STAT+

Sponsored By

Adobe STAT+ | Winners and losers from Medicare's list of drugs subject to price negotiation Naming 10 medicines to the Medicare drug price negotiation list is a milestone, and a point to start appraising the impact of the process. By Matthew Herper and Damian Garde STAT+ | As competition looms, Insulet sues a rival for allegedly stealing trade secrets on diabetes tech Insulet filed a lawsuit this month against EOFlow for stealing trade secrets in a case that could shake up the diabetes tech market. By Lizzy Lawrence Opinion: How the twin crises of climate change and poor public housing are harming people's health Public housing is populated by the elderly, the poor, and the sick — the populations most at-risk from climate change. By Arya Rao and Shira Hornstein Drew Angerer/Getty Images Opinion: Every senator should fill out a legislative advance directive Legislative advance directives that senators could complete before the start of each term might be a remedy to recent alarming moments. By Joseph J. Fins

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser